share_log

Argus Research Downgrades Silk Road Medical to Hold

Benzinga ·  Sep 21, 2023 20:17

Argus Research analyst Steve Silver downgrades Silk Road Medical (NASDAQ:SILK) from Buy to Hold.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment